CB
Commense Bio, Inc.
SEC filingBiotechnology · Boulder, CO
Amount raised$2.5Msold at filing
Total offering$2.7M$202K still open
Investors in the raise31count reported to the SEC
FiledJun 12, 2026first sale Jan 18, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Todd TurnerExecutive Officer, Director
Randall W. ViolaDirector
Erik PrenticeDirector
Joshua SmithDirector
Judith BoiceDirector
N. Stuart HarrisDirector
Executive officers, directors and promoters as listed on the Form D.